HDL and the Inflammatory Response Induced by LDL-derived Oxidized Phospholipids
Overview
Authors
Affiliations
Oxidation of low density lipoprotein (LDL) phospholipids containing arachidonic acid at the sn-2 position occurs when a critical concentration of "seeding molecules" derived from the lipoxygenase pathway is reached in LDL. When this critical concentration is reached, the nonenzymatic oxidation of LDL phospholipids produces a series of biologically active, oxidized phospholipids that mediate the cellular events seen in the developing fatty streak. Normal high density lipoprotein (HDL) contains at least 4 enzymes as well as apolipoproteins that can prevent the formation of the LDL-derived oxidized phospholipids or inactivate them after they are formed. In the sense that normal HDL can prevent the formation of or inactivate these inflammatory LDL-derived oxidized phospholipids, normal HDL is anti-inflammatory. HDL from mice that are genetically predisposed to diet-induced atherosclerosis became proinflammatory when the mice are fed an atherogenic diet, injected with LDL-derived oxidized phospholipids, or infected with influenza A virus. Mice that were genetically engineered to be hyperlipidemic on a chow diet and patients with coronary atherosclerosis, despite normal lipid levels, also had proinflammatory HDL. It is proposed that LDL-derived oxidized phospholipids and HDL may be part of a system of nonspecific innate immunity and that the detection of proinflammatory HDL may be a useful marker of susceptibility to atherosclerosis.
Guo J, Mutailipu K, Wen X, Yin J, You H, Qu S Lipids Health Dis. 2025; 24(1):9.
PMID: 39794792 PMC: 11721163. DOI: 10.1186/s12944-024-02411-7.
Fang M, Lei J, Hu W, Yang J, Lei T, Lei Y Sci Rep. 2024; 14(1):31228.
PMID: 39732738 PMC: 11682075. DOI: 10.1038/s41598-024-82491-8.
Atherogenic circulating lipoproteins in ischemic stroke.
Benitez S, Puig N, Camps-Renom P, Sanchez-Quesada J Front Cardiovasc Med. 2024; 11:1470364.
PMID: 39713216 PMC: 11659270. DOI: 10.3389/fcvm.2024.1470364.
Protective Role of High-Density Lipoprotein in Multiple Sclerosis.
Damiza-Detmer A, Pawelczyk M, Glabinski A Antioxidants (Basel). 2024; 13(11).
PMID: 39594418 PMC: 11591269. DOI: 10.3390/antiox13111276.
Guo K, Zeng J, Lu J, Guo Y, Shan P, Huang Y Front Med (Lausanne). 2024; 11:1446124.
PMID: 39544385 PMC: 11560784. DOI: 10.3389/fmed.2024.1446124.